Weimin Wang

8PUBLICATIONS
33CO-AUTHORS
Molecular targetsHaematological tumoursInnate immunityApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Medical infection agents (incl. prions)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (8)

|Jun 17, 2026
Intermediate accumulated upon interruption of fatty acid oxidation flux promotes tumoral ferroptosis and improves immunotherapy.

|Apr 21, 2026
TMEM87A suppresses ferroptosis and increases cancer immunotherapy resistance by maintaining the Golgi apparatus pH homeostasis.

|Feb 13, 2026
CCR8 Expression on Regulatory T Cells Reveals Trajectories of Tissue Adaptation and Protects Against Myocardial Infarction-Induced Tissue Damage.

Nana Li, Zhiheng Hao, Haoyi Yang

|Dec 29, 2025
Engineered Regulatory T Lymphocytes Promote Infarcted Heart Repair.

Min Zhang, Yongying Qin, Ting Zhou

|Aug 15, 2025
Targeting lipid scrambling potentiates ferroptosis and triggers tumor immune rejection.

Mengyun Yang, Ze Yu, Jieming Ping

|Jul 11, 2025
IFNγ augments TKI efficacy by alleviating protein unfolding stress to promote GSDME-mediated pyroptosis in hepatocellular carcinoma.

Xiaoxiao Li, Fujia Lu, Jie Zhou

Pageof 2

Frequent Collaborators

4 joint publications

Xiang Cheng

3 joint publications

Qian Chu

2 joint publications

Desheng Hu

2 joint publications

Chen Chen